Overview
Scott Brodie is an Ophthalmologist in New York, New York. Dr. Brodie is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, Cone-Rod Dystrophy, and Vitrectomy.
His clinical research consists of co-authoring 84 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 51 articles in the study of Retinoblastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
622 W 168th St, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mskcc Surgery Group
David Abramson is an Ophthalmologist in New York, New York. Dr. Abramson is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. His top areas of expertise are Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation.
Trustees Of Columbia University In The City Of New York
Brian Marr is an Ophthalmologist in New York, New York. Dr. Marr is rated as a Distinguished provider by MediFind in the treatment of Retinoblastoma. His top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.
Yale University
Anthony Daniels is an Ophthalmologist in New Haven, Connecticut. Dr. Daniels is rated as a Distinguished provider by MediFind in the treatment of Retinoblastoma. His top areas of expertise are Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, and Metastatic Uveal Melanoma. Dr. Daniels is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- RetinoblastomaDr. Brodie isElite. Learn about Retinoblastoma.
- Distinguished
- Retinitis PigmentosaDr. Brodie isDistinguished. Learn about Retinitis Pigmentosa.
- Advanced
- Cone DystrophyDr. Brodie isAdvanced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis Imperfecta
- Cone-Rod DystrophyDr. Brodie isAdvanced. Learn about Cone-Rod Dystrophy.
- Doyne Honeycomb Retinal DystrophyDr. Brodie isAdvanced. Learn about Doyne Honeycomb Retinal Dystrophy.
- Late-Onset Retinal DegenerationDr. Brodie isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Leber Congenital AmaurosisDr. Brodie isAdvanced. Learn about Leber Congenital Amaurosis.
- Experienced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Age-Related Macular Degeneration (ARMD)Dr. Brodie isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Birdshot ChorioretinopathyDr. Brodie isExperienced. Learn about Birdshot Chorioretinopathy.
- Blue Cone MonochromatismDr. Brodie isExperienced. Learn about Blue Cone Monochromatism.
- Brown SyndromeDr. Brodie isExperienced. Learn about Brown Syndrome.
- Chediak-Higashi SyndromeDr. Brodie isExperienced. Learn about Chediak-Higashi Syndrome.